The Catlins: Unparalleled Drug Testing Experience
Don H. Catlin, M.D., chief science officer and co-founder of ADSI, is considered a father of drug testing in sports. In 1982, he founded the UCLA Olympic Analytical Laboratory, the first anti-doping lab in the United States, and served at its director for 25 years. He oversaw drug testing at the Olympic, professional, collegiate and high school levels, and grew the lab into the world’s largest testing facility for performance-enhancing drugs.
Dr. Catlin is renowned for having developed and/or inaugurated many of the tests used to detect performance-enhancing substances, including artificial testosterone, darbepoetin, norbolethone, CERA for the equine, and THG.
In 2004, Dr. Catlin and his son, respected industry leader Oliver Catlin, founded The Catlin Consortium, a well-regarded group of organizations dedicated to ensuring not only clean competing environments for athletes but the safety of dietary and nutritional supplements and prescription and over-the-counter drug products for all consumers. The Catlin Consortium is comprised of three organizations: the nonprofit/NGO Anti-Doping Research (ADR) and the companies Anti-Doping Sciences Institute (ADSI) and Banned Substances Control Group (BSCG).
Dr. Catlin serves as Professor Emeritus of Molecular and Medical Pharmacology at the UCLA David Geffen School of Medicine and is a longtime member of the International Olympic Committee (IOC) Medical Commission. He has authored over 100 peer-reviewed articles in scientific publications and chapters in academic books.
For more about Dr. Catlin and his work, read a biographical profile on him from Current Biography. Reprinted from the March 2010 issue of Current Biography® published by The H.W. Wilson Company www.hwwilson.com.